Skip to main content

Promoting your publication

Individual articles are widely promoted by our marketing and communications teams in a variety of ways. This could be through email updates, table of contents, email alerts, postings on the BioMed Central homepage, social media, blogs and/or press releases. These may result in higher levels of views and downloads for each article.

We would encourage you to promote your article via your own email lists, social media, Listservs, distribution at conferences and any other innovative techniques you wish to adopt.

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.8
    5-year Journal Impact Factor: 4.2
    Source Normalized Impact per Paper (SNIP): 0.957
    SCImago Journal Rank (SJR): 0.968

    Speed 2024
    Submission to first editorial decision (median days): 8
    Submission to acceptance (median days): 124

    Usage 2024
    Downloads: 1,443,643
    Altmetric mentions: 320

News

New Content ItemEditor-in-Chief Dr Ben Tsang has been selected as a 2025 Distinguished Fellow by the Society for the Study of Reproduction (SSR) Awards Committee. Please join us in celebrating this amazing achievement. 

A new FDA approved phase I/II clinical trial on recurrent ovarian cancer is now open for enrollment.

Currently recruiting patients at the Brown Cancer Center, University of Louisville, Louisville, KY. UofL. IRB# 22.0392. NCT# 05610735. Please contact: Dr. Whitney Goldsberry or Dr. Sham S. Kakar.

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.